Kuros Biosciences Competitors and Similar CompaniesClear all
Kuros Biosciences's competitors and similar companies include Merus.
 Kuros Biosciences Kuros Biosciences is a biopharmaceutical company that engages in the development of biopharmaceutical products for tissue repair and bone regeneration. |  Merus Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients. | |
Founding Date | Founding Date 2000 | Founding Date 2003 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Zürich, CH HQ Bilthoven, NL Boston, US | Locations Utrecht, NL HQ Cambridge, US |
Employees | Employees 122 | Employees 260 |
Financial | ||
Revenue (est.) | Revenue (est.) $146.1m (FY, 2025) | Revenue (est.) $36.1m (FY, 2024) |
Cost of goods | Cost of goods $16.5m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $129.7m (FY, 2025) | Gross profit $36.1m (FY, 2024) |
Net income | Net income $2.5m (FY, 2025) | Net income ($215.3m) (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Merus
HQ
Utrecht, NL
Employees
260
Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
View company